Sales of OTC sleep aids are negligible in India due to restrictions on the sale of these products. Consumers need to visit a doctor and receive a prescription for products for sleep-related issues as self-medicating is not yet possible. Hence, the availability and consumption of OTC sleep aids is negligible. Unless restrictions are lifted or eased for the sale of OTC sleep aids then this situation is unlikely to change in India.

Euromonitor International’s Sleep Aids in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.